Zynex Current Ratio 2010-2023 | ZYXI
Zynex current ratio from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Zynex Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-12-31 | $0.09B | $0.02B | 4.74 |
| 2023-09-30 | $0.10B | $0.02B | 5.19 |
| 2023-06-30 | $0.11B | $0.01B | 7.63 |
| 2023-03-31 | $0.07B | $0.02B | 3.09 |
| 2022-12-31 | $0.07B | $0.02B | 3.30 |
| 2022-09-30 | $0.07B | $0.02B | 3.41 |
| 2022-06-30 | $0.07B | $0.02B | 3.75 |
| 2022-03-31 | $0.08B | $0.02B | 3.67 |
| 2021-12-31 | $0.08B | $0.02B | 3.62 |
| 2021-09-30 | $0.07B | $0.01B | 6.79 |
| 2021-06-30 | $0.06B | $0.01B | 6.95 |
| 2021-03-31 | $0.06B | $0.01B | 6.53 |
| 2020-12-31 | $0.06B | $0.01B | 6.23 |
| 2020-09-30 | $0.06B | $0.01B | 7.89 |
| 2020-06-30 | $0.03B | $0.01B | 4.96 |
| 2020-03-31 | $0.03B | $0.01B | 4.41 |
| 2019-12-31 | $0.02B | $0.01B | 4.34 |
| 2019-09-30 | $0.02B | $0.01B | 4.12 |
| 2019-06-30 | $0.02B | $0.00B | 4.12 |
| 2019-03-31 | $0.01B | $0.00B | 3.21 |
| 2018-12-31 | $0.01B | $0.01B | 2.05 |
| 2018-09-30 | $0.01B | $0.00B | 3.45 |
| 2018-06-30 | $0.01B | $0.00B | 3.14 |
| 2018-03-31 | $0.01B | $0.00B | 2.23 |
| 2017-12-31 | $0.01B | $0.00B | 2.08 |
| 2017-09-30 | $0.01B | $0.00B | 1.27 |
| 2017-06-30 | $0.00B | $0.01B | 0.64 |
| 2017-03-31 | $0.00B | $0.01B | 0.53 |
| 2016-12-31 | $0.00B | $0.01B | 0.44 |
| 2016-09-30 | $0.00B | $0.01B | 0.49 |
| 2016-06-30 | $0.00B | $0.01B | 0.41 |
| 2016-03-31 | $0.00B | $0.01B | 0.40 |
| 2015-12-31 | $0.00B | $0.01B | 0.37 |
| 2015-09-30 | $0.00B | $0.01B | 0.52 |
| 2015-06-30 | $0.00B | $0.01B | 0.55 |
| 2015-03-31 | $0.01B | $0.01B | 0.62 |
| 2014-12-31 | $0.01B | $0.01B | 0.71 |
| 2014-09-30 | $0.01B | $0.01B | 0.91 |
| 2014-06-30 | $0.01B | $0.01B | 0.87 |
| 2014-03-31 | $0.01B | $0.01B | 1.34 |
| 2013-12-31 | $0.01B | $0.01B | 1.42 |
| 2013-09-30 | $0.02B | $0.01B | 1.65 |
| 2013-06-30 | $0.02B | $0.01B | 1.67 |
| 2013-03-31 | $0.02B | $0.01B | 1.82 |
| 2012-12-31 | $0.02B | $0.01B | 1.77 |
| 2012-09-30 | $0.02B | $0.01B | 1.68 |
| 2012-06-30 | $0.02B | $0.01B | 1.68 |
| 2012-03-31 | $0.02B | $0.01B | 1.74 |
| 2011-12-31 | $0.02B | $0.01B | 1.85 |
| 2011-09-30 | $0.02B | $0.01B | 1.77 |
| 2011-06-30 | $0.02B | $0.01B | 1.87 |
| 2011-03-31 | $0.01B | $0.01B | 2.01 |
| 2010-12-31 | $0.01B | $0.01B | 2.26 |
| 2010-09-30 | $0.01B | $0.01B | 2.60 |
| 2010-06-30 | $0.01B | $0.00B | 2.54 |
| 2010-03-31 | $0.01B | $0.01B | 2.27 |
| 2009-12-31 | $0.01B | $0.00B | 2.73 |
| 2009-09-30 | $0.01B | $0.00B | 2.16 |
| 2009-06-30 | $0.01B | $0.01B | 1.92 |
| 2009-03-31 | $0.01B | $0.01B | 1.67 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.361B | $0.184B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.474B | 24.35 |
| Stryker (SYK) | United States | $128.161B | 31.78 |
| Boston Scientific (BSX) | United States | $106.966B | 34.07 |
| Medtronic (MDT) | Ireland | $106.730B | 15.11 |
| EssilorLuxottica (ESLOY) | France | $99.574B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.648B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.127B | 29.82 |
| ResMed (RMD) | United States | $27.032B | 27.03 |
| Terumo (TRUMY) | Japan | $25.476B | 35.98 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.896B | 16.03 |
| Baxter (BAX) | United States | $20.785B | 15.16 |
| Koninklijke Philips (PHG) | Netherlands | $19.474B | 15.53 |
| Insulet (PODD) | United States | $11.711B | 61.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.741B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.934B | 23.64 |
| BellRing Brands (BRBR) | United States | $7.285B | 39.17 |
| Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
| Haemonetics (HAE) | United States | $4.379B | 22.40 |
| Perrigo (PRGO) | Ireland | $4.232B | 12.10 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Envista Holdings (NVST) | United States | $3.485B | 13.26 |
| Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.46 |
| QuidelOrtho (QDEL) | United States | $2.730B | 9.91 |
| Neogen (NEOG) | United States | $2.679B | 25.77 |
| Green Thumb Industries (GTBIF) | United States | $2.630B | 83.33 |
| ICU Medical (ICUI) | United States | $2.357B | 17.58 |
| TG Therapeutics (TGTX) | United States | $2.161B | 699.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.928B | 0.00 |
| Owens & Minor (OMI) | United States | $1.895B | 18.19 |
| Verano Holdings (VRNOF) | United States | $1.790B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
| InMode (INMD) | Israel | $1.458B | 7.55 |
| LeMaitre Vascular (LMAT) | United States | $1.437B | 47.43 |
| National Vision Holdings (EYE) | United States | $1.388B | 43.24 |
| AdaptHealth (AHCO) | United States | $1.300B | 9.78 |
| Warby Parker (WRBY) | United States | $1.287B | 0.00 |
| AtriCure (ATRC) | United States | $1.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.982B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.899B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.779B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.712B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.693B | 14.98 |
| Evolus (EOLS) | United States | $0.666B | 0.00 |
| Quanterix (QTRX) | United States | $0.613B | 0.00 |
| Jin Medical (ZJYL) | China | $0.547B | 0.00 |
| Valneva SE (VALN) | France | $0.540B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.509B | 11.02 |
| PetIQ (PETQ) | United States | $0.487B | 18.17 |
| TerrAscend (TSNDF) | Canada | $0.478B | 0.00 |
| ZimVie (ZIMV) | United States | $0.430B | 26.35 |
| OraSure Technologies (OSUR) | United States | $0.421B | 6.96 |
| Biote (BTMD) | United States | $0.417B | 3.96 |
| Aurora Cannabis (ACB) | Canada | $0.393B | 0.00 |
| Surmodics (SRDX) | United States | $0.371B | 40.11 |
| Viemed Healthcare (VMD) | United States | $0.314B | 31.11 |
| Cerus (CERS) | United States | $0.301B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.241B | 14.70 |
| Organigram Holdings (OGI) | Canada | $0.199B | 0.00 |
| Veru (VERU) | United States | $0.193B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.192B | 0.00 |
| Omeros (OMER) | United States | $0.176B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.163B | 0.00 |
| High Tide (HITI) | Canada | $0.160B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.134B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.130B | 65.20 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
| InterCure (INCR) | Israel | $0.122B | 20.54 |
| Fonar (FONR) | United States | $0.102B | 8.80 |
| Cellectar Biosciences (CLRB) | United States | $0.099B | 0.00 |
| MariMed (MRMD) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.088B | 0.00 |
| Brainsway (BWAY) | Israel | $0.084B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.060B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 15.04 |
| Bright Green (BGXX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.54 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |